Results 251 to 260 of about 50,545 (304)

Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models. [PDF]

Curr Top Behav Neurosci
Harris HM, Moore CF, Jenkins BW, Bedillion MF, Weerts EM, Arout CA.   +5 more
europepmc   +1 more source

Cannabinoids and Extracellular Vesicles as Potential Biomarkers and Therapeutic Targets in Neuropsychiatric Disorders: A Hypothesis-Driven Review. [PDF]

Pharmaceuticals (Basel)
Marques BL, Lirio PHC, Vicente MA, Unzueta-Larrinaga P, Urigüen L, Campos AC.   +5 more
europepmc   +1 more source

Saccharomyces cerevisiae as a toxicological model to study synthetic cannabinoids and its pyrolysis products

, 2015
Carla Ferreira, Joana Couceiro, R. Soeiro, João Paulo Noronha, Cátia Santos, Tiago F. Outeiro, Sandra Tenreiro, Alexandre Quintas   +7 more
openalex   +1 more source

In Vitro Antimicrobial Effect of Tetrahydrocannabinol on Streptococcus mutans and Its Anticariogenic Potential. [PDF]

Int Dent J
Zhai H, Zhang Y, Kim M, Zhou X, Ferracciolo J, Krukonis E, Liu C, Zhou Z.   +7 more
europepmc   +1 more source

Ewing sarcoma-related pain: potential role of medical cannabis monotherapy in symptom management - a case report. [PDF]

J Cannabis Res
De Virgilio Suglia C, Spaccavento FA, Turco F, De Trizio A, Giannuzzi R, Tafuri S.   +5 more
europepmc   +1 more source

Differential Regulatory Effects of Cannabinoids and Vitamin E Analogs on Cellular Lipid Homeostasis and Inflammation in Human Macrophages. [PDF]

Antioxidants (Basel)
Li M, Deo S, Daunert S, Zingg JM.
europepmc   +1 more source